Cargando…
Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol
Neurodevelopmental disorders are a heterogeneous group of conditions with overlapping symptomatology and fluctuating developmental trajectories that transcend current diagnostic categorisation. There is a need for validated screening instruments which dimensionally assess symptomatology from a holis...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657806/ https://www.ncbi.nlm.nih.gov/pubmed/34886563 http://dx.doi.org/10.3390/ijerph182312837 |
_version_ | 1784612586907500544 |
---|---|
author | Masi, Anne Azim, Syeda Ishra Lam-Cassettari, Christa Dadds, Mark Mendoza Diaz, Antonio Henry, Georgina Karlov, Lisa Lin, Ping-I Mallitt, Kylie-Ann Montgomery, Alicia Strnadová, Iva Whitehouse, Andrew Eapen, Valsamma |
author_facet | Masi, Anne Azim, Syeda Ishra Lam-Cassettari, Christa Dadds, Mark Mendoza Diaz, Antonio Henry, Georgina Karlov, Lisa Lin, Ping-I Mallitt, Kylie-Ann Montgomery, Alicia Strnadová, Iva Whitehouse, Andrew Eapen, Valsamma |
author_sort | Masi, Anne |
collection | PubMed |
description | Neurodevelopmental disorders are a heterogeneous group of conditions with overlapping symptomatology and fluctuating developmental trajectories that transcend current diagnostic categorisation. There is a need for validated screening instruments which dimensionally assess symptomatology from a holistic, transdiagnostic perspective. The primary aim is to co-design a Neurodevelopment Assessment Scale (NAS), a user-friendly transdiagnostic assessment inventory that systematically screens for all signs and symptoms commonly encountered in neurodevelopmental disorders. Our first objective is to undertake development of this tool, utilising co-design principles in partnership with stakeholders, including both those with lived experience of neurodevelopmental disorders and service providers. Our second objective is to evaluate the face validity, as well as the perceived utility, user-friendliness, suitability, and acceptability (i.e., ‘social validity’), of the NAS from the perspective of parents/caregivers and adults with neurodevelopmental disorders, clinicians, and service providers. Our third objective is to ascertain the psychometric properties of the NAS, including content validity and convergent validity. The NAS will provide an efficient transdiagnostic tool for evaluating all relevant signs, symptoms, and the dimensional constructs that underpin neurodevelopmental presentations. It is anticipated that this will maximise outcomes by enabling the delivery of personalised care tailored to an individual’s unique profile in a holistic and efficient manner. |
format | Online Article Text |
id | pubmed-8657806 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86578062021-12-10 Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol Masi, Anne Azim, Syeda Ishra Lam-Cassettari, Christa Dadds, Mark Mendoza Diaz, Antonio Henry, Georgina Karlov, Lisa Lin, Ping-I Mallitt, Kylie-Ann Montgomery, Alicia Strnadová, Iva Whitehouse, Andrew Eapen, Valsamma Int J Environ Res Public Health Article Neurodevelopmental disorders are a heterogeneous group of conditions with overlapping symptomatology and fluctuating developmental trajectories that transcend current diagnostic categorisation. There is a need for validated screening instruments which dimensionally assess symptomatology from a holistic, transdiagnostic perspective. The primary aim is to co-design a Neurodevelopment Assessment Scale (NAS), a user-friendly transdiagnostic assessment inventory that systematically screens for all signs and symptoms commonly encountered in neurodevelopmental disorders. Our first objective is to undertake development of this tool, utilising co-design principles in partnership with stakeholders, including both those with lived experience of neurodevelopmental disorders and service providers. Our second objective is to evaluate the face validity, as well as the perceived utility, user-friendliness, suitability, and acceptability (i.e., ‘social validity’), of the NAS from the perspective of parents/caregivers and adults with neurodevelopmental disorders, clinicians, and service providers. Our third objective is to ascertain the psychometric properties of the NAS, including content validity and convergent validity. The NAS will provide an efficient transdiagnostic tool for evaluating all relevant signs, symptoms, and the dimensional constructs that underpin neurodevelopmental presentations. It is anticipated that this will maximise outcomes by enabling the delivery of personalised care tailored to an individual’s unique profile in a holistic and efficient manner. MDPI 2021-12-06 /pmc/articles/PMC8657806/ /pubmed/34886563 http://dx.doi.org/10.3390/ijerph182312837 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Masi, Anne Azim, Syeda Ishra Lam-Cassettari, Christa Dadds, Mark Mendoza Diaz, Antonio Henry, Georgina Karlov, Lisa Lin, Ping-I Mallitt, Kylie-Ann Montgomery, Alicia Strnadová, Iva Whitehouse, Andrew Eapen, Valsamma Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol |
title | Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol |
title_full | Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol |
title_fullStr | Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol |
title_full_unstemmed | Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol |
title_short | Co-Design of a Neurodevelopment Assessment Scale: A Study Protocol |
title_sort | co-design of a neurodevelopment assessment scale: a study protocol |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657806/ https://www.ncbi.nlm.nih.gov/pubmed/34886563 http://dx.doi.org/10.3390/ijerph182312837 |
work_keys_str_mv | AT masianne codesignofaneurodevelopmentassessmentscaleastudyprotocol AT azimsyedaishra codesignofaneurodevelopmentassessmentscaleastudyprotocol AT lamcassettarichrista codesignofaneurodevelopmentassessmentscaleastudyprotocol AT daddsmark codesignofaneurodevelopmentassessmentscaleastudyprotocol AT mendozadiazantonio codesignofaneurodevelopmentassessmentscaleastudyprotocol AT henrygeorgina codesignofaneurodevelopmentassessmentscaleastudyprotocol AT karlovlisa codesignofaneurodevelopmentassessmentscaleastudyprotocol AT linpingi codesignofaneurodevelopmentassessmentscaleastudyprotocol AT mallittkylieann codesignofaneurodevelopmentassessmentscaleastudyprotocol AT montgomeryalicia codesignofaneurodevelopmentassessmentscaleastudyprotocol AT strnadovaiva codesignofaneurodevelopmentassessmentscaleastudyprotocol AT whitehouseandrew codesignofaneurodevelopmentassessmentscaleastudyprotocol AT eapenvalsamma codesignofaneurodevelopmentassessmentscaleastudyprotocol |